Eleazar Sukenik

John Hunt Joins GemmaCert as Director of Sales for North America

Retrieved on: 
Monday, November 22, 2021
Technology, Towson University, Industry, Awareness, Solution, Business, Hebrew University of Jerusalem, Business administration, Eleazar Sukenik, TEL, Breeding, Growth, Drug

TEL AVIV, Israel, Nov. 22, 2021 /PRNewswire/ --GemmaCert Ltd., a leading provider of cannabis diagnostics solutions, announced today that industry veteran John Hunt is joining the company as Director of Sales for North America.

Key Points: 
  • TEL AVIV, Israel, Nov. 22, 2021 /PRNewswire/ --GemmaCert Ltd., a leading provider of cannabis diagnostics solutions, announced today that industry veteran John Hunt is joining the company as Director of Sales for North America.
  • John will head sales execution in the United States, Canada, and Mexico and will help execute the company's strategy moving forward.
  • Most recently he was the Global Sales Director for Purpl Scientific.
  • Avi Rosenbaum, GemmaCert's Director of Global Sales, added, "We're excited to have John join our senior team during a period of significant growth and innovation here at GemmaCert.

Sufresca Accelerates Its Green Solution to Reduce Waste and Plastic

Retrieved on: 
Thursday, November 18, 2021
Amos, Grain, Edible, Hunger, CEO, CSO, Industry, Science and technology in Asia, Eleazar Sukenik, OurCrowd, Faculty, Weight loss, Environment, Water loss, Hebrew University of Jerusalem, US, Research, TEL, Food, Investment, Life, Vegetable, Agricultural technology, Agriculture

Sufresca developed an edible, biodegradable, water-based emulsion composed of wholly natural food ingredients and inbuilt with advanced modified atmosphere properties.

Key Points: 
  • Sufresca developed an edible, biodegradable, water-based emulsion composed of wholly natural food ingredients and inbuilt with advanced modified atmosphere properties.
  • This sustainable solution can extend shelf life by up to several weeks, saving plastic packaging and extending shipment time.
  • Sufresca developed a high-feasibility business model for straightforward application of its solution into existing systems.
  • "Retailers and packaging houses are seeking cost-effective solutions to reduce waste and are kind to the planet," asserts Boker-Ferri.

Sufresca Accelerates Its Green Solution to Reduce Waste and Plastic

Retrieved on: 
Thursday, November 18, 2021
Amos, Grain, Edible, Hunger, CEO, CSO, Industry, Science and technology in Asia, Eleazar Sukenik, OurCrowd, Faculty, Weight loss, Environment, Water loss, Hebrew University of Jerusalem, US, Research, TEL, Food, Investment, Life, Vegetable, Agricultural technology, Agriculture

TEL AVIV, Israel, Nov. 18, 2021 /PRNewswire/ -- AgriTech start-up Sufresca, Ltd. is breathing new life into the global pursuit for combatting food waste and plastic use. The company optimized its novel invisible edible coating designed to extend the shelf-life of fresh produce and expanding its use to fit a range of fresh fruit and vegetables. Sufresca also shares the business model for its simple plug-in system to benefit retailers and growers.

Key Points: 
  • Sufresca developed an edible, biodegradable, water-based emulsion composed of wholly natural food ingredients and inbuilt with advanced modified atmosphere properties.
  • This sustainable solution can extend shelf life by up to several weeks, saving plastic packaging and extending shipment time.
  • Sufresca developed a high-feasibility business model for straightforward application of its solution into existing systems.
  • "Retailers and packaging houses are seeking cost-effective solutions to reduce waste and are kind to the planet," asserts Boker-Ferri.

Passwordless Authentication Vendor Secret Double Octopus Continues Executive Build Out with Yair Averbuch Named as Chief Financial Officer

Retrieved on: 
Tuesday, November 16, 2021
Data Management, Security, Technology, Other Technology, Software, Networks, Internet, MFA, Secret Double Octopus, Ilan Averbuch, Gartner, Eleazar Sukenik, Emerging technologies, Applied Materials, NASDAQ, CEO, MBA, Octopus, Initial public offering, Secrecy, Workforce, Hebrew University of Jerusalem, TechRadar, CFO, SDO, Management

Secret Double Octopus (SDO), the global leader in next generation workforce authentication, today announced Yair Averbuch as Chief Financial Officer.

Key Points: 
  • Secret Double Octopus (SDO), the global leader in next generation workforce authentication, today announced Yair Averbuch as Chief Financial Officer.
  • In his role he will lead and manage all Double Octopus financial and operational activities as it continues its global growth and continued market expansion.
  • We are excited to have Yair round out our executive team in key areas this year, said Raz Rafaeli, CEO and Co-founder of Secret Double Octopus.
  • I am thrilled to join Secret Double Octopus to help organizational workforces begin their journeys to passwordless with the recognized leader in the space, said Averbuch.

W. P. Carey School of Business at ASU names new dean -- Ohad Kadan to join the school in July 2022

Retrieved on: 
Monday, November 15, 2021
University, U.S. News & World Report, Olin Business School, Student, Leadership, Eleazar Sukenik, Center, Education, Movement, First Step to Nobel Prize in Physics, Doctor of Philosophy, Department, Growth, Entrepreneurship, Washington University in St. Louis, Research, Hebrew University of Jerusalem, Arizona, W. P. Carey School of Business, Faculty, Hillman, PetSmart, Marketing, ASU, Risk, Westcor, Arizona State University, Management, Education reform

"I am thrilled to be joining W. P. Carey and ASU and am looking forward to the continued growth of an already outstanding school," said Kadan.

Key Points: 
  • "I am thrilled to be joining W. P. Carey and ASU and am looking forward to the continued growth of an already outstanding school," said Kadan.
  • "One of the things that most excites me about W. P. Carey is our commitment to inclusive access to world-class business education."
  • "W. P. Carey prides itself on channeling ASU's spirit of innovation and rethinking what's next in business education," he said.
  • The W. P. Carey School of Business at Arizona State University is one of the top-ranked business schools in the United States.

Colombia's President Visits Start-Up Nation Central in Search for Innovation Inspiration in Israel

Retrieved on: 
Wednesday, November 10, 2021
Climate change, Industry, Ecosystem, Mentorship, Eleazar Sukenik, Duque, COP26, Organization, CEO, KKL-JNF, Technology, Water, Goal, International, Collaboration, Program, SUM, Hebrew University of Jerusalem, Carbon, Biotechnology, Molecular biology, Food, Solution, Coffee, Health policy, Innovation, Peres Center for Peace, Climate, TEL, Food security, Agriculture, Drug, Online gambling, Pharmaceutical industry, Renewable energy

TEL AVIV, Israel, Nov. 10, 2021 /PRNewswire/ -- Colombia's President Ivan Duque concluded a three-day diplomatic visit to Israel on Tuesday with a meeting with Israeli innovation leaders at Start-Up Nation Central Headquarters in Tel Aviv. Duque met with Start-Up Nation Central's CEO Avi Hasson and other senior executives to hear from them about what it takes to develop an advanced ecosystem like Israel's.

Key Points: 
  • That's what we want to do with Israel and with Start-Up Nation Central."
  • Start-Up Nation Central CEO Avi Hasson:"I would like to thank President Duque and the senior Colombian delegation for meeting with us.
  • Start-Up Nation Central catalyzes growth opportunities by bringing Israeli tech innovation to global business and societal challenges.
  • Established in 2013 and headquartered in Tel-Aviv, Israel, Start-Up Nation Central is a not-for-profit organization funded by philanthropy.

Colombia's President Visits Start-Up Nation Central in Search for Innovation Inspiration in Israel

Retrieved on: 
Wednesday, November 10, 2021
Climate change, View, Industry, Ecosystem, Mentorship, Eleazar Sukenik, Duque, COP26, Organization, CEO, KKL-JNF, Technology, Water, Goal, International, Multimedia, Collaboration, Program, SUM, Hebrew University of Jerusalem, Carbon, Biotechnology, Molecular biology, Food, Solution, Coffee, Health policy, Innovation, Peres Center for Peace, Climate, TEL, Food security, Agriculture, Online gambling, Pharmaceutical industry, Renewable energy, Drug

TEL AVIV, Israel, Nov. 10, 2021 /PRNewswire/ -- Colombia's President Ivan Duque concluded a three-day diplomatic visit to Israel on Tuesday with a meeting with Israeli innovation leaders at Start-Up Nation Central Headquarters in Tel Aviv.

Key Points: 
  • TEL AVIV, Israel, Nov. 10, 2021 /PRNewswire/ -- Colombia's President Ivan Duque concluded a three-day diplomatic visit to Israel on Tuesday with a meeting with Israeli innovation leaders at Start-Up Nation Central Headquarters in Tel Aviv.
  • Start-Up Nation Central CEO Avi Hasson:"I would like to thank President Duque and the senior Colombian delegation for meeting with us.
  • Start-Up Nation Central catalyzes growth opportunities by bringing Israeli tech innovation to global business and societal challenges.
  • Established in 2013 and headquartered in Tel-Aviv, Israel, Start-Up Nation Central is a not-for-profit organization funded by philanthropy.

Arbe Appoints Veteran Chief Financial Officer Karine Pinto-Flomenboim

Retrieved on: 
Monday, November 8, 2021
Securities Exchange Act of 1934, Robotics, Safety, Treasury, Industry, Private Securities Litigation Reform Act, Financial condition report, Eleazar Sukenik, Economics, Leadership, Applied Materials, Security (finance), Risk, Growth, Klein, Radar, Solution, Securities Act of 1933, Forward-looking statement, Perception, Hebrew University of Jerusalem, Caesarstone, U.S. Securities and Exchange Commission, Intel, IPO, TIBA, SEC, Analysis, Result, Accounting, TEL, Conversation, Management

TEL AVIV, Israel, Nov. 8, 2021 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) ("Arbe"), a global leader in next-generation 4D Imaging Radar Solutions, announced today the appointment of Karine Pinto-Flomenboim as its Chief Financial Officer, effective today.

Key Points: 
  • TEL AVIV, Israel, Nov. 8, 2021 /PRNewswire/ -- Arbe Robotics Ltd. (Nasdaq: ARBE) ("Arbe"), a global leader in next-generation 4D Imaging Radar Solutions, announced today the appointment of Karine Pinto-Flomenboim as its Chief Financial Officer, effective today.
  • As Chief Financial Officer, Pinto-Flomenboim will lead the company's financial planning, analysis and reporting, tax, accounting, and treasury, reporting directly to Kobi Marenko, Chief Executive Officer.
  • In her most recent role, Pinto-Flomenboim served as Chief Financial Officer at TIBA Parking Systems, a leading manufacturer of parking access and revenue control systems.
  • "Karine Pinto-Flomenboim is a seasoned Chief Financial Officer that has a wealth of experience working with publicly traded companies, her outstanding leadership and invaluable insight will further fuel the growth of the company," says Kobi Marenko, Chief Executive Officer of Arbe.

GCANRx Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy

Retrieved on: 
Monday, November 8, 2021
Securities Exchange Act of 1934, Population, Yissum Research Development Company of the Hebrew University, Maintenance, Private Securities Litigation Reform Act, Industry, Novartis, Eleazar Sukenik, Merck, Security (finance), Boston Scientific, Lists of diseases, Trial of the century, Cannabinoid, Microglia, Research, Securities Act of 1933, Hebrew University of Jerusalem, Annual report, Twitter, Invention, Company, Intel, U.S. Securities and Exchange Commission, Cannabidiol, GLOBE, Solution, Therapy, Johnson & Johnson, Nature, ICL, Cannabis, Patient, Risk, Uncertainty, OTC, Pharmaceutical industry

Dr. Aran will lead the clinical study while Professor Tal Burstyn-Cohen, Ph.D. of the Hebrew University, through the Yissum Research Development Company, will be leading the preclinical study.

Key Points: 
  • Dr. Aran will lead the clinical study while Professor Tal Burstyn-Cohen, Ph.D. of the Hebrew University, through the Yissum Research Development Company, will be leading the preclinical study.
  • The preclinical study aims to assess the synergistic impact of various combinations of the neuroprotective therapeutic in a preclinical model.
  • The Company expects the study to generate in vitro data that will demonstrate significant neuroprotective attributes of the therapeutic.
  • To receive the latest information about GCANRx sign up to the investor email at https://bit.ly/2ZNlBoj or follow @GCANRX on Twitter.

Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of ARMOR Study and Reports Third Quarter 2021 Financial Results

Retrieved on: 
Monday, November 8, 2021
F1, Mortality, Safety, Hepatic encephalopathy, Ascites, Cirrhosis, Clinical trial, Eleazar Sukenik, Terminology, EMA, Liver, COVID-19, Overweight, Medication, Annual report, Forward-looking statement, Perception, Risk, Hebrew University of Jerusalem, Kinetics, ARMOR, Patient, NASH, SEC, Inflammation, Pharmacokinetics, Physician, Fibrosis, Time, MELD, FDA, Biopsy, Drug development, Pharmaceutical industry

Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases.

Key Points: 
  • Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases.
  • Our lead compound, Aramchol, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.
  • We are also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide.
  • Patients are randomized (1:1:1) into three groups with post-baseline liver biopsy being performed at 24 weeks, 48 weeks, or 72 weeks, respectively.